Korea Ginseng Corporation
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- -
- Established
- 1999-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.kgc.or.kr
Clinical Trials
7
Active:0
Completed:5
Trial Phases
1 Phases
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (100.0%)Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
Not Applicable
Completed
- Conditions
- Platelet AggregationBlood Pressure DisordersCardiovascular DiseasesVasodilation
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Korea Ginseng Corporation
- Target Recruit Count
- 108
- Registration Number
- NCT06236243
- Locations
- 🇺🇸
Valiance Clinical Research, Tarzana, California, United States
Safety for 24 Weeks Intake of Korean Red Ginseng in Adults
Not Applicable
Completed
- Conditions
- HypertensionHyperlipidemiaHealthyDiabetes
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- Korea Ginseng Corporation
- Target Recruit Count
- 1000
- Registration Number
- NCT02428998
- Locations
- 🇰🇷
Catholic Universtiy of Korea. Seoul St Mary's Hospital, Seoul, Korea, Republic of
Korean Red Ginseng in Treating Patients With Fatigue Caused by Chemotherapy for Colorectal Cancer
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- Korea Ginseng Corporation
- Target Recruit Count
- 438
- Registration Number
- NCT02039635
- Locations
- 🇰🇷
Korea Ginseng Corporation, Shinseongdong, Daejeon, Korea, Republic of
News
No news found